Building upon our prior demonstration that Cav2 predominantly localizes within the nerves of the HNSCC microenvironment, we sought to elucidate the effects of neural-specific Cav2 ablation on tumor progression. Here, CAV2 is linked to head and neck squamous cell carcinoma.